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Introduction
The Aryl Hydrocarbon receptor (AhR) is a ubiquitous, ligand activated basic helix-loop-helix transcription factor extensively characterized in the context of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) toxicity, as reviewed by White and Birnbaum (White and Birnbaum, 2009) . Upon ligand binding, the deduced canonical signaling mechanism involves translocation of the cytosolic chaperonebound AhR into the nucleus, followed by dimerization with the Arnt protein and binding of the AhR-Arnt complex to cis-acting xenobiotic response elements (XRE) associated with target genes to regulate gene expression (Beischlag et al., 2008) . Furthermore, the research has revealed that the AhR is responsive to a diverse array of ligands (Denison et al., 2011; Soshilov and Denison, 2014) , and that AhR functionality can be differentially altered by the specific ligand binding, resulting in distinct transcriptomic responses (Goodale et al., 2013; Hruba et al., 2011; Ovando et al., 2010) . Although the precise mechanism for the differential responsiveness remains unresolved, the possibility that ligand-dependent effects may be attributed to recruitment of distinct coactivators has been proposed (Zhang et al., 2008) .
In addition to the many exogenous AhR ligands identified to date, the repertoire of AhR agonists recently increased to include several endogenous compounds identified as tryptophan catabolites (Lowe et al., 2014; Opitz et al., 2011; Rannug et al., 1995; Wei et al., 1998) . These include kynurenine, 6-formylindolo [3,2-b] carbazole and cinnabarinic acid (CA).
Using CA, we recently detected stanniocalcin 2 (Stc2) as a novel AhR target gene (Joshi et al., 2015a) .
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Strikingly, Stc2 was completely unresponsive to induction by the exogenous AhR agonists TCDD, 3-methylchloranthrene or β-napthoflavone (Harper et al., 2012) .
Conversely, CYP1A1 gene induction was unresponsive to CA but robustly induced by TCDD (Harper et al., 2012; Joshi et al., 2015a) . Chromatin immunoprecipitation results confirmed that the mutually exclusive agonistspecific transcriptional response was dependent on AhR-DNA binding to XREs located in the regulatory regions of each gene. In order to interrogate the molecular basis for the agonist specificity, mass spectrometry was performed on immunoaffinity purified AhR complexes recovered after treatment with either TCDD or CA. Metastasis-associated protein 2 (MTA2) was identified as a cofactor recruited by AhR-Arnt complex exclusively in response to CA. MTA2, a known chromatin modifying protein, a component of nucleosome remodeling and deacetylation complex (NuRD) with the capacity to both repress and activate gene expression (Matsusue et al., 2001; Miccio et al., 2010; Yao and Yang, 2003) . In the present study, we demonstrate CA-specific recruitment of the MTA2-AhR complex to XREs in the Stc2 promoter, with concomitant acetylation of lysine 5 on histone H4 (H4K5Ac) at the Stc2 promoter and transcriptional activation. These data identify an epigenetic mark associated with AhR activation and agonist-specific recruitment of MTA2 resulting in selective target gene induction. In addition, this study establishes a critical regulatory role for MTA2 in CA-dependent Stc2 mediated protection against ethanol-induced liver apoptosis.
This article has not been copyedited and formatted. The final version may differ from this version. (Fazio et al., 2012) intraperitoneally for 2 hr and 24 hr. Primary hepatocytes were isolated using collagenase perfusion method as described previously (Harper et al., 2012) . Cells were plated at a density of 10 6 cells/cm 2 in Williams' E medium containing penicillin (100 U/ml), streptomycin (100 µg/ml) and 5% fetal bovine serum, and treated with DMSO, 6 nM TCDD or 30 µM CA dissolved in DMSO for 24 hr. For MTA2 knockdown studies, primary hepatocytes were transiently transfected with ON-TARGETplus MTA2 small interfering RNA (siRNA, Thermo
Fischer Scientific, Waltham, MA) for 24 hr. Metafectene PRO (Biontex Laboratories GmbH, München, Germany) was used as a transfection reagent.
Immunoaffinity purification and LC/MS-MS of AhR complexes.
Liver nuclear extracts were prepared from C57BL/6 mice using sucrose cushion as described previously (Wilson et al., 2013 Scientific) as per manufacturer's instructions. Antibody conjugated magnetic beads were equilibrated with TGH buffer (50mM HEPES (pH 7.4), 150mM NaCl, 10% glycerol, 1.5 mM MgCl2, 1 mM EGTA, 1 % Triton X-100, 1 mM PMSF, 10 mM NaF, 1 mM Na3VO4, 5 µl/ml protease inhibitor cocktail and 1 µg/ml BSA) and incubated with nuclear extracts from vehicle, TCDD-treated and CA-treated C57BL/6 mice at 4˚C for 6 hr. Beads were washed six time in 10 volumes TGH buffer, and the AhR complexes eluted using freshly prepared 500 µl of aqueous 0.5 N NH4OH, 0.5 mM EDTA solution. The eluent was dried, resuspended in SDS-PAGE sample buffer, and fractionated using 4-20% gels (Bio-Rad, and CA (12 mg/kg) for 2 hr, or on primary hepatocytes isolated from C57BL/6 mice treated for 2 hr with vehicle (DMSO), 6 nM TCDD and 30 µM CA as described previously (Joshi et al., 2015a) . Briefly, following treatment, liver tissues from AhR floxed and AhR CKO mice were finely minced and crosslinked with 1% formaldehyde in phosphate buffered saline at room temperature for 10 min. Samples were homogenized using a Dounce homogenizer and centrifuged at 3200g for 5 min at 4˚C. Pellets were resuspended in 2 ml of cell lysis buffer (5 mM PIPES pH 8, 85 mM KCl, 0.5% NP40, 4 µl protease inhibitor cocktail).
Samples were incubated on ice for 15 min, centrifuged 3200g for 5 min at 4˚C.
Pellets were processed using ChIP-IT Express Enzymatic Kit and CA (12 mg/kg) treated mice at 2 hr and 24 hr (Fig. 3) . The data show that the AhR interacts with MTA2 only after CA treatment.
Direct binding of AhR and MTA2 to Stc2 promoter in vivo in response to CA.
Previous studies established that the AhR-Arnt complex is recruited to a region of Recognizing that CA promotes an AhR-MTA2 interaction, we sought to determine if MTA2 was recruited to the XRE cluster in the Stc2 promoter. ChIP assays were performed on whole liver tissue targeting the XREs in the Stc2 and CYP1A1 promoter regions (Fig. 4) . The results reveal that both the AhR and MTA2 bind selectively to the Stc2 promoter in CA-dependent manner (Fig. 4A ).
In contrast, TCDD treatment was unable to recruit AhR and MTA2 to Stc2 promoter ( Fig. 4A ), but as expected, successfully recruited the AhR to the CYP1A1 promoter (Fig. 4B) . Moreover, TCDD-induced AhR recruitment to the CYP1A1 promoter occurred independently of MTA2 (Fig. 4B ).
Re-ChIP experiments confirmed concurrent binding of the AhR and MTA2 to the Stc2
This article has not been copyedited and formatted. The final version may differ from this version. 5A ). Quantitative RT-PCR showed that loss of MTA2 expression markedly attenuated Stc2 induction in CA treated hepatocytes, but had no effect on CYP1A1 expression (Fig. 5B) . These data clearly demonstrate that MTA2 is Table 1 ). Acetylation of histone H4 lysines was not observed in TCDD and vehicle treated nuclear extracts (Supplemental Table 1 ).
Furthermore CA-treated nuclear extracts immunoprecipitated with anti-H4
antibody and subjected to MS analysis confirmed acetylation of histone H4 lysines 5, 8, 12 and 16 ( Fig. 6A and B) . The mass of all fragment ions in the MS/MS along with the precursor ions were manually compared against the theoretical mono-isotopic masses calculated using Protein Prospector 
CA-induced MTA2-AhR recruitment to the Stc2 promoter is required for histone
H4 lysine 5 acetylation. Murine primary hepatocytes were transiently transfected with scrambled RNA (control siRNA) or MTA2 siRNA to suppress MTA2 expression as described for Figure 5 . ChIP studies using the anti-H4K5Ac antibody revealed that CA treatment, but not TCDD treatment, led to formation of the H4K5Ac epigenetic mark in the Stc2 promoter encompassing the XRE cluster (Fig. 7A) . Moreover, the H4K5Ac mark was not observed in the CYP1A1
This article has not been copyedited and formatted. The final version may differ from this version. promoter. Significantly, H4K5Ac formation was dependent on both MTA2 expression ( Fig. 7B ) and AhR expression ( Fig. 7C and D) . Collectively, the data strongly suggest that transcriptional activation of the Stc2 gene by the AhR in response to CA is dependent on the selective recruitment of MTA2-conceivably as part of the NuRD complex-resulting in epigenetic modifications including H4K5Ac leading to chromatin changes supporting enhance gene expression.
Furthermore, these studies offer a mechanistic insight into how AhR agonists can selectively regulate gene expression.
MTA2 is a key regulator of Stc2 mediated cytoprotection against ethanol-induced
apoptosis. We previously showed that CA-mediated AhR-dependent Stc2 induction was absolutely necessary to protect hepatocytes against intrinsic Our finding that the differential responsiveness of CYP1A1 and Stc2 to TCDD and CA, respectively could not be recapitulated through AhR-Arnt protein DNA binding in vitro (Suppl. Fig. 1 ) reinforced the notion that this agonist-specific process depends on the native chromatin architecture and specific epigenetic histone modifications. The results provide compelling evidence that: 1) the AhR recruits MTA2 in a CA-dependent manner selectively to the Stc2 regulatory region (Fig. 4) , 2) that DNA binding of the AhR-MTA2 complex is absolutely dependent on both proteins (Fig. 5) , and 3) that MTA2 recruitment to the Stc2 regulatory region is necessary for histone H4 acetylation (Fig. 7) . The LC-MS/MS results showed that AhR-MTA2 DNA binding induced histone H4 lysine acetylation at positions K5, K8, K12, and K16. Acetylation of H4K5 was independently verified using immunological methods. Western blotting using the CYP1A1 promoter is presented as percentage of vehicle input DNA. C) PCR was performed on DNA isolated in sequential re-ChIP experiment using antibodies against the AhR followed by MTA2. For 4A and 4B, mixed effects two-way ANOVA models were used. For 4C, mixed effects one-way ANOVA model was used. Following significant overall F test from ANOVA models, the post-hoc multiple comparison tests were performed for the pre-specified comparisons adjusted by Bonferroni procedure. * indicates p <0.05, n = 3 independent mice. Table 2) C) Nuclear proteins isolated from livers of C57BL/6 mice treated with vehicle, TCDD (20 µg/kg) and CA (12 mg/kg) for 2 and 24 hr were analyzed by western blotting using an anti-H4K5Ac antibody (n = 3). Anti-histone H4 was used as a control. 
